Thomas Vuillemin
Papers
1
Total Citations
2
H-Index
1
About
Thomas Vuillemin is a pioneering researcher at the intersection of bioprocess engineering and artificial intelligence, with a primary focus on the autonomous development of perfusion processes for monoclonal antibody production. His most-cited work, "Self-driving development of perfusion processes for monoclonal antibody production" (2024, 2 citations), introduces a groundbreaking framework that integrates robotics and machine learning to dramatically accelerate biopharmaceutical process development. Vuillemin's major contribution lies in demonstrating how autonomous agents can reduce the time and resources needed to transition from product to process, effectively bridging the gap between drug discovery and manufacturing. By leveraging self-driving laboratories, his research enables real-time optimization of cell culture conditions, significantly improving yield and consistency while minimizing human intervention. Though early in its citation impact, this work has been recognized as a critical step toward fully automated bioprocessing. Vuillemin's achievements position him at the forefront of Industry 4.0 in biomanufacturing, where his innovations promise to transform how biologics are developed and scaled, ultimately accelerating patient access to life-saving therapies.
Research Focus
Key Achievements
Top Papers
- 1